摘要
黏膜免疫系统在呼吸道、胃肠道等黏膜中提供局部免疫,黏膜表面免疫失调是引起胃肠道疾病和呼吸系统疾病的重要原因,支气管哮喘就是其中之一。中医治疗支气管哮喘常用肺肠合治法,因肺与大肠相表里,二者生理上相互依存,病理上互相影响,治疗上相互为用。同时,肺肠合治还指因为肺肠的黏膜系统功能相似、机制相近,可共同发挥免疫防御作用。从中西医两个角度深入研究肺合大肠的物质基础以及肺肠合治法治疗支气管哮喘的作用机制,为支气管哮喘的治疗提供了明确的思路和方法。
Mucosal immune system provides local immunity in respiratory tract,gastrointestinal tract and other mucosa.Mucosal surface immune imbalance is an important cause of gastrointestinal diseases and respiratory diseases.Bronchial asthma is one of them.Chinese medicine treatment of bronchial asthma commonly uses the method of lung-intestine combined therapy,because the lung and large intestine are superficies and interior,they are physiologically interdependent,pathologically affected and mutually used in treatment.At the same time,lung-intestine combined therapy also means that the functions of the mucosal system of the lung and intestine are similar and the mechanism is similar,which can play the role of immune defense together.From the perspective of Chinese medicine and Western medicine,the material basis of lung combined with large intestine and the mechanism of lung-intestine combined therapy in the treatment of bronchial asthma are deeply studied,which provided clear ideas and methods for the treatment of bronchial asthma.
作者
尹诺男
王萌
孟博博
闫曙光
魏海梁
惠毅
YIN Nuonan;WANG Meng;MENG Bobo;YAN Shuguang;WEI Hailiang;HUI Yi(Shaanxi University of Chinese Medicine,Xianyang Shaanxi China 712046)
出处
《中医学报》
CAS
2020年第11期2293-2297,共5页
Acta Chinese Medicine
基金
国家自然科学基金青年科学基金项目(8170152146)
陕西中医药大学学科创新团队建设项目(2019-YL05)。
关键词
支气管哮喘
肺肠合治
黏膜免疫
bronchial asthma
lung-intestine combined therapy
mucosal immunity